Premium
OnKure Therapeutics Inc (OKUR)
NASDAQ
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Reneo Pharmaceuticals Inc is a clinical stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing ... Reneo Pharmaceuticals Inc is a clinical stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.13 | 2.65848670757 | 4.89 | 5.6 | 4.61 | 40328 | 5.09436473 | CS |
| 4 | -0.98 | -16.3333333333 | 6 | 6.176 | 4.61 | 32112 | 5.32058428 | CS |
| 12 | -5.63 | -52.8638497653 | 10.65 | 11 | 4.575 | 108735 | 7.19342631 | CS |
| 26 | -13.38 | -72.7173913043 | 18.4 | 19.9992 | 4.575 | 89957 | 10.58827814 | CS |
| 52 | -13.38 | -72.7173913043 | 18.4 | 19.9992 | 4.575 | 89957 | 10.58827814 | CS |
| 156 | -13.38 | -72.7173913043 | 18.4 | 19.9992 | 4.575 | 89957 | 10.58827814 | CS |
| 260 | -13.38 | -72.7173913043 | 18.4 | 19.9992 | 4.575 | 89957 | 10.58827814 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
